ID

20192

Description

Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00327093

Lien

https://clinicaltrials.gov/show/NCT00327093

Mots-clés

Versions (1)
  1. 11/02/2017 11/02/2017 -
Téléchargé le

11 février 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Colorectal Cancer NCT00327093

Anglais

Eligibility Colorectal Cancer NCT00327093

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients >= 18 years old
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
patients with colon or rectal carcinoma histologically proven
Description

Colon Carcinoma | Rectal Carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0699790
UMLS CUI [2]
C0007113
patients with metastases (synchronous or metachronous)
Description

Metastases Synchronous | Metastases Timepoint Different

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0439580
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C1705242
patients with associated extra-hepatic disease (asymptomatic primary tumor or extra-hepatic metastases)
Description

Disease Extrahepatic Associated | Primary tumor Asymptomatic | Neoplasm Metastasis Extrahepatic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1517058
UMLS CUI [1,3]
C0332281
UMLS CUI [2,1]
C0677930
UMLS CUI [2,2]
C0231221
UMLS CUI [3,1]
C0027627
UMLS CUI [3,2]
C1517058
performance status (world health organization [who]) = 0, 1, or 2
Description

WHO performance status scale

Type de données

boolean

Alias
UMLS CUI [1]
C1298650
life expectancy >= 3 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
patients with normal haematological, kidney, and liver parameters (pnn > 1.5 x 10^9/l, platelets > 100 10^9/l, total bilirubin <= 1.25 x upper limit of normal (uln), asat/alat <= 5 x uln, creatinaemia <= 135 µmol/l (1.5 mg/dl)
Description

Hematologic function | Renal function | Liver function | Absolute neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
UMLS CUI [4]
C0948762
UMLS CUI [5]
C0032181
UMLS CUI [6]
C1278039
UMLS CUI [7]
C0201899
UMLS CUI [8]
C0201836
UMLS CUI [9]
C0201976
no cardiac or coronary insufficiency untreated
Description

Heart failure Untreated | Coronary artery insufficiency Untreated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0542052
UMLS CUI [2,2]
C0332155
at least 4 weeks between surgery and study beginning
Description

Operative Surgical Procedure Previous

Type de données

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C0205156
patients can have a biopsy of the hepatic lesion identified by ultrasound.
Description

Lesion of liver Biopsy | Identification Ultrasonography

Type de données

boolean

Alias
UMLS CUI [1,1]
C0577053
UMLS CUI [1,2]
C0005558
UMLS CUI [2,1]
C0205396
UMLS CUI [2,2]
C0041618
informed consent signed.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with symptomatic tumors (colon or rectal)
Description

Colon Carcinoma Symptomatic | Rectal Carcinoma Symptomatic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0699790
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C0007113
UMLS CUI [2,2]
C0231220
patients with others tumors not cured
Description

Malignant Neoplasms Cure Lacking

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0679252
UMLS CUI [1,3]
C0332268
patients who cannot be treated by 5-fluorouracil (5-fu) and/or irinotecan because of special medical conditions or other serious disease.
Description

Fluorouracil | Irinotecan | Untreated Due to Medical condition Special | Untreated Due to Disease Serious

Type de données

boolean

Alias
UMLS CUI [1]
C0016360
UMLS CUI [2]
C0123931
UMLS CUI [3,1]
C0332155
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C3843040
UMLS CUI [3,4]
C0205555
UMLS CUI [4,1]
C0332155
UMLS CUI [4,2]
C0678226
UMLS CUI [4,3]
C0012634
UMLS CUI [4,4]
C0205404
patients who participated in another clinical trial since less than 30 days
Description

Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
pregnancy or breast-feeding women
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who cannot be treated because of active infection or other serious disease.
Description

Untreated Due to Communicable Disease | Untreated Due to Disease Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332155
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0009450
UMLS CUI [2,1]
C0332155
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0012634
UMLS CUI [2,4]
C0205404
Retour au début de la page

Similar models

Eligibility Colorectal Cancer NCT00327093

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients >= 18 years old
boolean
C0001779 (UMLS CUI [1])
Colon Carcinoma | Rectal Carcinoma
Item
patients with colon or rectal carcinoma histologically proven
boolean
C0699790 (UMLS CUI [1])
C0007113 (UMLS CUI [2])
Metastases Synchronous | Metastases Timepoint Different
Item
patients with metastases (synchronous or metachronous)
boolean
C0027627 (UMLS CUI [1,1])
C0439580 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C1705242 (UMLS CUI [2,3])
Disease Extrahepatic Associated | Primary tumor Asymptomatic | Neoplasm Metastasis Extrahepatic
Item
patients with associated extra-hepatic disease (asymptomatic primary tumor or extra-hepatic metastases)
boolean
C0012634 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C0332281 (UMLS CUI [1,3])
C0677930 (UMLS CUI [2,1])
C0231221 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3,1])
C1517058 (UMLS CUI [3,2])
WHO performance status scale
Item
performance status (world health organization [who]) = 0, 1, or 2
boolean
C1298650 (UMLS CUI [1])
Life Expectancy
Item
life expectancy >= 3 months
boolean
C0023671 (UMLS CUI [1])
Hematologic function | Renal function | Liver function | Absolute neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Creatinine measurement, serum
Item
patients with normal haematological, kidney, and liver parameters (pnn > 1.5 x 10^9/l, platelets > 100 10^9/l, total bilirubin <= 1.25 x upper limit of normal (uln), asat/alat <= 5 x uln, creatinaemia <= 135 µmol/l (1.5 mg/dl)
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0948762 (UMLS CUI [4])
C0032181 (UMLS CUI [5])
C1278039 (UMLS CUI [6])
C0201899 (UMLS CUI [7])
C0201836 (UMLS CUI [8])
C0201976 (UMLS CUI [9])
Heart failure Untreated | Coronary artery insufficiency Untreated
Item
no cardiac or coronary insufficiency untreated
boolean
C0018801 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0542052 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Operative Surgical Procedure Previous
Item
at least 4 weeks between surgery and study beginning
boolean
C0543467 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Lesion of liver Biopsy | Identification Ultrasonography
Item
patients can have a biopsy of the hepatic lesion identified by ultrasound.
boolean
C0577053 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0205396 (UMLS CUI [2,1])
C0041618 (UMLS CUI [2,2])
Informed Consent
Item
informed consent signed.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Colon Carcinoma Symptomatic | Rectal Carcinoma Symptomatic
Item
patients with symptomatic tumors (colon or rectal)
boolean
C0699790 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0007113 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
Malignant Neoplasms Cure Lacking
Item
patients with others tumors not cured
boolean
C0006826 (UMLS CUI [1,1])
C0679252 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Fluorouracil | Irinotecan | Untreated Due to Medical condition Special | Untreated Due to Disease Serious
Item
patients who cannot be treated by 5-fluorouracil (5-fu) and/or irinotecan because of special medical conditions or other serious disease.
boolean
C0016360 (UMLS CUI [1])
C0123931 (UMLS CUI [2])
C0332155 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C3843040 (UMLS CUI [3,3])
C0205555 (UMLS CUI [3,4])
C0332155 (UMLS CUI [4,1])
C0678226 (UMLS CUI [4,2])
C0012634 (UMLS CUI [4,3])
C0205404 (UMLS CUI [4,4])
Study Subject Participation Status
Item
patients who participated in another clinical trial since less than 30 days
boolean
C2348568 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Untreated Due to Communicable Disease | Untreated Due to Disease Serious
Item
patients who cannot be treated because of active infection or other serious disease.
boolean
C0332155 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0009450 (UMLS CUI [1,3])
C0332155 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0012634 (UMLS CUI [2,3])
C0205404 (UMLS CUI [2,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial